461 related articles for article (PubMed ID: 30487530)
1. Clinical potential of mass spectrometry-based proteogenomics.
Zhang B; Whiteaker JR; Hoofnagle AN; Baird GS; Rodland KD; Paulovich AG
Nat Rev Clin Oncol; 2019 Apr; 16(4):256-268. PubMed ID: 30487530
[TBL] [Abstract][Full Text] [Related]
2. Proteogenomics drives therapeutic hypothesis generation for precision oncology.
Lei JT; Zhang B
Br J Cancer; 2021 Jul; 125(1):1-3. PubMed ID: 33767418
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomics for understanding oncology: recent advances and future prospects.
Subbannayya Y; Pinto SM; Gowda H; Prasad TS
Expert Rev Proteomics; 2016; 13(3):297-308. PubMed ID: 26697917
[TBL] [Abstract][Full Text] [Related]
4. The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.
Rodriguez H; Zenklusen JC; Staudt LM; Doroshow JH; Lowy DR
Cell; 2021 Apr; 184(7):1661-1670. PubMed ID: 33798439
[TBL] [Abstract][Full Text] [Related]
5. Cancer proteogenomics: current impact and future prospects.
Mani DR; Krug K; Zhang B; Satpathy S; Clauser KR; Ding L; Ellis M; Gillette MA; Carr SA
Nat Rev Cancer; 2022 May; 22(5):298-313. PubMed ID: 35236940
[TBL] [Abstract][Full Text] [Related]
6. Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.
Dimitrakopoulos L; Prassas I; Diamandis EP; Charames GS
Crit Rev Clin Lab Sci; 2017 Sep; 54(6):414-432. PubMed ID: 29025326
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine.
Joshi SK; Piehowski P; Liu T; Gosline SJC; McDermott JE; Druker BJ; Traer E; Tyner JW; Agarwal A; Tognon CE; Rodland KD
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():455-479. PubMed ID: 37738504
[TBL] [Abstract][Full Text] [Related]
8. Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine.
Ang MY; Low TY; Lee PY; Wan Mohamad Nazarie WF; Guryev V; Jamal R
Clin Chim Acta; 2019 Nov; 498():38-46. PubMed ID: 31421119
[TBL] [Abstract][Full Text] [Related]
9. Proteogenomics: Key Driver for Clinical Discovery and Personalized Medicine.
Barbieri R; Guryev V; Brandsma CA; Suits F; Bischoff R; Horvatovich P
Adv Exp Med Biol; 2016; 926():21-47. PubMed ID: 27686804
[TBL] [Abstract][Full Text] [Related]
10. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.
Hernandez-Valladares M; Vaudel M; Selheim F; Berven F; Bruserud Ø
Expert Rev Proteomics; 2017 Aug; 14(8):649-663. PubMed ID: 28693350
[TBL] [Abstract][Full Text] [Related]
11. A proteogenomics data-driven knowledge base of human cancer.
Liao Y; Savage SR; Dou Y; Shi Z; Yi X; Jiang W; Lei JT; Zhang B
Cell Syst; 2023 Sep; 14(9):777-787.e5. PubMed ID: 37619559
[TBL] [Abstract][Full Text] [Related]
12. Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer.
Wang L; Wrobel JA; Xie L; Li D; Zurlo G; Shen H; Yang P; Wang Z; Peng Y; Gunawardena HP; Zhang Q; Chen X
Cell Chem Biol; 2018 May; 25(5):619-633.e5. PubMed ID: 29503206
[TBL] [Abstract][Full Text] [Related]
13. Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation.
Dimitrakopoulos L; Prassas I; Berns EMJJ; Foekens JA; Diamandis EP; Charames GS
Clin Chem Lab Med; 2017 Aug; 55(9):1291-1304. PubMed ID: 28157690
[TBL] [Abstract][Full Text] [Related]
14. Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.
Fu S; Liu X; Luo M; Xie K; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2017 Apr; 14(4):351-362. PubMed ID: 28276747
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
Chiou SH; Lee KT
Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
[TBL] [Abstract][Full Text] [Related]
16. Proteogenomics unveils mechanistic insights to precision oncology.
Dou Y; Katsnelson L; Zhang B; Fenyö D; Liu T
Clin Transl Med; 2023 Nov; 13(11):e1477. PubMed ID: 38009415
[No Abstract] [Full Text] [Related]
17. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
18. Moonshot Objectives: Catalyze New Scientific Breakthroughs-Proteogenomics.
Rodland KD; Piehowski P; Smith RD
Cancer J; 2018; 24(3):121-125. PubMed ID: 29794536
[TBL] [Abstract][Full Text] [Related]
19. [Precision oncology from a proteogenomics perspective].
Huang Y; Wu S; Shu K; Zhu Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3616-3627. PubMed ID: 36305397
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and genomic profiling of pancreatic cancer.
Ansari D; Torén W; Zhou Q; Hu D; Andersson R
Cell Biol Toxicol; 2019 Aug; 35(4):333-343. PubMed ID: 30771135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]